Innovating Works

GENETIKAPLUS LTD

Desconocido
RxMine: A simple blood test to choose the best treatment for each patient with depression. GENETIKAPLUS LTD tramitó un HORIZON EUROPE HORIZON-EIC-2022-ACCELERATOR-01 Major depressive disorder affects around 300M people globally and is the second leading cause of disability, with up to 14 years of life los...
2022-09-15 - 2025-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.